Valuation

ALCAlcon AG

StockStock瑞士Health careEU retail: available

+0.2% today · −4.5% over a year

5/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 39% of the instruments we score

Trend: among the weakest. Dividend yield 0.48%.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricALCSector medianvs median
P/E35.021.2 · n=1165% above
P/B1.61.8 · n=1714% below
P/S3.33.5 · n=127% below
EV/EBIT27.517.8 · n=1054% above
Free-cash-flow yield5.0%5.0% · n=15near the median
Dividend yield0.48%1.60% · n=5870% below
Return on equity4.5%4.5% · n=17near the median
Return on invested capital4.6%6.1% · n=1424% below
Gross margin55.2%56.5% · n=9near the median

Value factor: 55 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
NVSNovartis AG21.36.517.95.9%3.1%9/10
NOVNNovartis AG21.26.417.85.9%2.9%10/10
SNYSanofi11.71.316.17.9%5.0%7/10
SANSanofi SA11.61.315.98.0%5.6%8/10
ALCAlcon35.11.627.65.0%0.5%3/10
STESTERIS28.13.121.14.1%0.8%6/10
BNTXBioNTech SE—1.0—1.4%0.0%—/10
ICLRICON plc337.91.560.96.2%0.0%3/10
CRSPCRISPR Therapeutics AG—2.8—−7.7%0.0%1/10
ABCLAbCellera Biologics—3.9—−3.4%0.0%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 12月 2025 · filed 24 2月 2026